News

The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.
The Trump administration’s proposed cuts at the National Institutes of Health and Food and Drug Administration could lower ...
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
FDA employees are spooked by increasing political involvement in regulatory decisions, frustrated by the impact of cuts to administrative staff who supported drug reviews and inspections, and fed ...
For years, inspectors have uncovered dirty equipment, contaminated supplies and fraudulent testing records in some overseas factories — serious safety and quality breaches that can sicken or kill ...
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...
Thousands of health workers lost their jobs this week after a U.S. Supreme Court ruling cleared the way for the Trump ...
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
Amid news reports describing the layoffs at the FDA, Kennedy did not specify how many people would be reinstated. ProPublica spoke to 10 current and former FDA staff members and leaders in recent ...
Beyond staff cuts, the departures of investigators in recent months have left less experienced people tasked with rooting out dangerous manufacturing practices.